Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 | P11229 | 16/20 | 0.41 |
| ▸ | CCKBR | P32239 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.35 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.34 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.34 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1502479 | 0.84 | CHRM1 (0.42) | CHRM1CCKBRALDH1A1HSD17B10CHRM2 | |
| SCHEMBL29466721 | 0.81 | CHRM1 (0.38) | CHRM1CCKBRALDH1A1HSD17B10CHRM2 | |
| SCHEMBL6873638 | 0.78 | CHRM1 (0.38) | CHRM1CCKBRALDH1A1HSD17B10CHRM2 | |
| SCHEMBL23885006 | 0.76 | CDK1 (0.31) | TRPV4 | |
| SCHEMBL8415766 | 0.73 | CHRM1 (0.37) | CHRM1CCKBRALDH1A1HSD17B10CHRM2 | |
| Hydrochloric Acid SCHEMBL8414655 | 0.72 | CHRM1 (0.36) | CHRM1CCKBRALDH1A1HSD17B10CHRM2 | |
| SCHEMBL8417370 | 0.71 | CYP3A4 (0.59) | CHRM1CCKBRALDH1A1KCNH2 | |
| SCHEMBL3739722 | 0.71 | ALDH1A1 (0.42) | CCKBRALDH1A1HSD17B10 | |
| SCHEMBL17850498 | 0.71 | ALDH1A1 (0.31) | ALDH1A1HSD17B10 | |
| SCHEMBL928489 | 0.71 | ALDH1A1 (0.45) | CHRM1ALDH1A1HSD17B10TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025104079-A1 | SALICYLIC ACID AND PICOLINIC ACID DERIVATIVES AS INHIBITORS OF ENERGY COUPLING FACTOR (ECF) TRANSPORTERS FOR THE TREATMENT OF BACTERIAL INFECTIONS | Helmholtz-Zentrum für Infektionsforschung GmbH (DE) | 2025-05-22 | — | — | WO | disclosed |
| WO-2008124524-A2 | ARYL SULFONAMIDE COMPOUNDS AS MODULATORS OF THE CCK2 RECEPTOR | JANSSEN PHARMACEUTICA N.V. (BE) | 2008-10-16 | — | — | WO | disclosed |